T-Cell homing to the pancreas in autoimmune mouse model of diabetes: In vivo MR imaging

被引:33
|
作者
Billotey, C [1 ]
Aspord, C [1 ]
Beuf, O [1 ]
Piaggio, E [1 ]
Gazeau, F [1 ]
Janier, MF [1 ]
Thivolet, C [1 ]
机构
[1] Univ Lyon 1, Hop Neurol, CERMEP, F-69365 Lyon, France
关键词
D O I
10.1148/radiol.2362040603
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To evaluate the efficiency of T-cell labeling with anionic magnetic nanoparticles (AMNPs) and in vivo magnetic resonance (MR) imaging monitoring of T-cell homing to the pancreas. MATERIALS AND METHODS: In vivo MR images of pancreas were obtained with a 7-T MR system in 12 NOD (nonobese diabetic) mice at I I and 20 days after injection of AMNP-loaded or unloaded T cells. Homing of loaded T cells in pancreatic lymph nodes was detected by the presence of a focal dark spot with T2(star) effect in a caudal area of the pancreas. Detection of loaded T cells in pancreatic islets was evaluated by comparison of histograms of MR signal intensity generated in whole pancreas in mice injected with loaded and unloaded T cells. Homing of loaded T cells was confirmed at transmission electronic microscopy (TEM). Fifty-six mice underwent all experiments. RESULTS: Focal dark spots with T2(star) effect were observed at 11 days in all three mice injected with loaded T cells and in none of the three mice injected with unloaded T cells. At 20 days, a more diffuse negative enhancement of the whole pancreas was noticed in one mouse injected with loaded T cells than in three mice injected with unloaded T cells. Presence of loaded T cells was confirmed with TEM. In vitro and in vivo tests confirmed that survival and function were not altered by loading. CONCLUSION: The ability of MR imaging to depict cell homing in living organisms at least 20 days after cell labeling was demonstrated, opening the way of follow-up in autoimmune diseases and cell therapy. (c) RSNA, 2005.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 50 条
  • [1] The 2C T-cell transgenic mouse: An in vivo model of allospecific cytotoxic T-cell activation and homing
    Stegall, MD
    Elices, M
    Shepard, G
    Gup, C
    Ninova, D
    Ferguson, D
    Gill, RG
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 779 - 779
  • [2] T-CELL INVOLVEMENT IN AUTOIMMUNE DIABETES IN THE NOD MOUSE
    WANG, Y
    MCDUFFIE, M
    LAFFERTY, KJ
    DIABETES, 1988, 37 (05) : A8 - A8
  • [3] T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes
    Babad, Jeffrey
    Geliebter, Ari
    DiLorenzo, Teresa P.
    IMMUNOLOGY, 2010, 131 (04) : 459 - 465
  • [4] PEPTIDE-INDUCED T-CELL TOLERANCE TO PREVENT AUTOIMMUNE DIABETES IN A TRANSGENIC MOUSE MODEL
    AICHELE, P
    KYBURZ, D
    OHASHI, PS
    ODERMATT, B
    ZINKERNAGEL, RM
    HENGARTNER, H
    PIRCHER, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 444 - 448
  • [5] T-cell promiscuity in autoimmune diabetes
    Li, Li
    Wang, Bo
    Frelinger, Jeffrey A.
    Tisch, Roland
    DIABETES, 2008, 57 (08) : 2099 - 2106
  • [6] CD8+ T-CELL HOMING TO THE PANCREAS IN THE NONOBESE DIABETIC MOUSE IS CD4+ T-CELL-DEPENDENT
    THIVOLET, C
    BENDELAC, A
    BEDOSSA, P
    BACH, JF
    CARNAUD, C
    JOURNAL OF IMMUNOLOGY, 1991, 146 (01): : 85 - 88
  • [8] Measurement of T-cell autoreactivity in autoimmune diabetes
    Dosch, HM
    Becker, DJ
    DIABETOLOGIA, 2000, 43 (03) : 386 - 387
  • [9] Pathogenic T-cell clones in autoimmune diabetes: More lessons from the NOD mouse
    Haskins, K
    ADVANCES IN IMMUNOLOGY, VOL 87, 2005, 87 : 123 - 162
  • [10] Development of a mouse model for studying in vivo T-cell receptor mutations
    Umeki, S
    Suzuki, T
    Kusunoki, Y
    Seyama, T
    Fujita, S
    Kyoizumi, S
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 393 (1-2) : 37 - 46